Sedation in the ICU
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Remimazolam Tosilate for Sedation in the ICU (NCT06222294) | Jiangsu HengRui Medicine Co., Ltd. | 2024-03-12 |
| Effects of Sedation, TEmperature and Pressure After Cardiac Arrest and REsuscitation on Major Adverse Kidney Events (STEPCARE-MAKE) (NCT07579390) | Helsinki University Central Hospital | 2023-08-17 |
| A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU (NCT05913336) | Jiangsu HengRui Medicine Co., Ltd. | 2023-06-27 |
| A Study of Remimazolam Tosilate for Sedation in the ICU (NCT05152303) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2022-10-12 |
Track Sedation in the ICU automatically
Every clearance here is in the API, with alerts when new ones post.